KING OF PRUSSIA, Pa., July 17, 2023 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its second quarter ended June 30, 2023, after the market closes on Tuesday, July 25, 2023. There will be a conference call for investors and analysts at 9:00 a.m. Eastern time on Wednesday, July 26, 2023
A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call.
Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico.
Last Trade: | US$174.80 |
Daily Change: | 1.14 0.66 |
Daily Volume: | 537,445 |
Market Cap: | US$10.260B |
March 11, 2025 February 26, 2025 October 29, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load